Replies to post #4559 on GTC Biotherapeutics (fka GTCB)

[croumagnon]

"Satisfied?"

Yes, thank you. I look forward to an update by Dr. Cox. Hopefully it will be sooner than later...

[kris_kade]

Dew, I agree with your optimism. It was particularly interesting to hear the upbeat presentation by Dr Cox & others during the recent CC.

One doesn't casually use the words 'update the progress' unless something is in the works.

[10nisman]

US Partnership....

Dew/Board,

What Companies do you think Cox is talking to with respect to a potential partnership in the US for Atryn? Assuming Atryn gets approval in the US wouldn't it make the most economic sense for a potential partner to just purchase all of GTCB ($2-4/pps) vs. some type of upfront money ($20-50 million) and profit sharing? I'm a little surprised with the share price lagging that no one has thrown out a $2-4 takeover offer.

TIA,
10nis

[voodoo in my basemen]

<<From Dr. Cox’s remarks on the 2Q07 CC (emphasis added):>>........

<< large, well financed, commercial partner is an important objective for GTC to achieve the market presence and opportunity which we believe ATryn represents, and I look forward to updating you on our progress.>>

Dew et all,

not that much forecast value;
but at which stage was partnering in Europe announced?
Was it end of phase II or just before/after filing?

What are the assets both for partner as well for the company?

V.